Xiaoyan Wang

6PUBLICATIONS
12CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersVeterinary anaesthesiology and intensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 03, 2026
Differential [18F]FAPI-42 and [18F]FDG uptake patterns distinguish desmoid tumours from GISTs on PET/CT imaging.

Chunhui Wu, Xiaoyan Wang, Xiaojie Lin

|Nov 21, 2025
Induction chemotherapy plus camrelizumab followed by concurrent chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma: a single-arm phase II trial.

Fang Peng, Jialiang Wu, Huimin Lian

|Oct 15, 2025
18F-FDG PET/CT and contrast-enhanced CT evaluation of lymph node status after neoadjuvant immunochemotherapy in patients with esophageal squamous cell carcinoma.

Yuhong Wang, Xin Hu, Tianhong Yang

|Aug 15, 2024
Predictive performance of [18F]F-fibroblast activation protein inhibitor (FAPI)-42 positron emission tomography/computed tomography (PET/CT) in evaluating response of recurrent or metastatic gastrointestinal stromal tumors: complementary or alternative to [18F]fluorodeoxyglucose (FDG) PET/CT?

Chunhui Wu, Fang Wen, Fangzeng Lin

|Aug 30, 2022
[18F]FAPI-42 PET/CT versus [18F]FDG PET/CT for imaging of recurrent or metastatic gastrointestinal stromal tumors.

Chunhui Wu, Xinhua Zhang, Yu Zeng

Pageof 1

Frequent Collaborators

2 joint publications

Chao Cheng

1 joint publications

Fang Peng

1 joint publications

Jialiang Wu

1 joint publications

Shuang Wu